Cassandra Newsom, Psy.D., director of the Translational Research Core in Autism and Neurodevelopment of Civitan International Research Center, has completed participation in Phase 2 Clinical Trials of a new drug, NNZ-2591, that shows promising results for a devastating neurodevelopmental disorder called Pitt-Hopkins Syndrome (PTHS).

Two researchers have been named Civitan Emerging Scholars for 2024-2025 by the Civitan International Research Center for neurodevelopmental disorders.

The new, five-year grant will support research in the UAB Alzheimer’s Disease Research Center to address dementia disparities in the Deep South.

A platform for undergraduate students to advance their research, the UAB Summer Research Academy (SRA) launched its seventh installment of the program on June 3, 2024. This competitive research program provides summer scholarships for students in the joint health sciences while preparing them for advancement to graduate or medical scientist training programs.

Camerron M. Crowder, Ph.D., professor in the Department of Neurobiology, has been awarded the 2023 Provost’s Awards for Faculty Excellence in Undergraduate Research.

HaoSheng Sun, Ph.D., has been recognized as a 2023 Freeman Hrabowski Scholar. This program is an extension of the Howard Hughes Medical Institute (HHMI).

The drug appears to help strengthen pathways in the brain, improving the ability of neurons to communicate with each other.

The distinct cell populations were identified by single-nucleus RNA sequencing of 21,600 cells of the rat ventral tegmental area, located in the midbrain.

NIH selects UAB and UA as research sites for a longitudinal study on child development since pregnancy. 

UAB and Civitan International have met a $20 million philanthropic milestone.